Creative Biosciences, a Chinese biotechnology start-up focusing on colorectal cancer detection, announced on Friday the completion of a RMB300 million (US$44.64 million) series B round of financing led by Boston-born investment firm IDG Capital and Chinese private equity firm CDH Investments. Returning investors including Chinese private equity firm CD Capital, and two investment funds affiliated […] IDG Capital, CDH Investments Lead $44M Series B Round In Chinese Biotech Start-Up comes originally from China Money Network. All Rights Reserved.